UnitedHealth Group Incorporated (NYSE:UNH) Position Reduced by Daymark Wealth Partners LLC

Daymark Wealth Partners LLC trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 1.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 115,109 shares of the healthcare conglomerate's stock after selling 1,144 shares during the quarter. UnitedHealth Group makes up 2.1% of Daymark Wealth Partners LLC's portfolio, making the stock its 11th biggest position. Daymark Wealth Partners LLC's holdings in UnitedHealth Group were worth $60,288,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently modified their holdings of the business. Range Financial Group LLC lifted its position in shares of UnitedHealth Group by 12.6% in the 1st quarter. Range Financial Group LLC now owns 634 shares of the healthcare conglomerate's stock worth $332,000 after buying an additional 71 shares during the last quarter. CMH Wealth Management LLC increased its holdings in shares of UnitedHealth Group by 1.8% in the 1st quarter. CMH Wealth Management LLC now owns 13,852 shares of the healthcare conglomerate's stock worth $7,255,000 after acquiring an additional 240 shares during the period. Moss Adams Wealth Advisors LLC increased its holdings in shares of UnitedHealth Group by 8.8% in the 1st quarter. Moss Adams Wealth Advisors LLC now owns 4,485 shares of the healthcare conglomerate's stock worth $2,349,000 after acquiring an additional 363 shares during the period. NewSquare Capital LLC increased its holdings in shares of UnitedHealth Group by 418.0% in the 1st quarter. NewSquare Capital LLC now owns 259 shares of the healthcare conglomerate's stock worth $136,000 after acquiring an additional 209 shares during the period. Finally, Greystone Financial Group LLC acquired a new stake in shares of UnitedHealth Group in the 1st quarter worth about $9,146,000. 87.86% of the stock is currently owned by institutional investors.

Insider Buying and Selling at UnitedHealth Group

In other news, CFO John F. Rex purchased 17,175 shares of the company's stock in a transaction dated Friday, May 16th. The shares were bought at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the transaction, the chief financial officer now directly owns 203,796 shares in the company, valued at $59,329,091.52. This trade represents a 9.20% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the company's stock in a transaction dated Friday, May 16th. The stock was purchased at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the transaction, the chief executive officer now owns 679,493 shares of the company's stock, valued at approximately $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired 109,408 shares of company stock worth $31,607,768 over the last ninety days. 0.33% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several research firms have commented on UNH. Truist Financial reissued a "buy" rating and set a $360.00 target price (down previously from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Argus cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Monday, April 21st. Morgan Stanley lowered their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. Wall Street Zen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Finally, Raymond James cut shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research note on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have issued a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $428.43.

UnitedHealth Group Stock Performance

UNH stock opened at $303.24 on Monday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a market cap of $275.08 billion, a P/E ratio of 19.56, a P/E/G ratio of 1.37 and a beta of 0.44. The firm has a 50 day simple moving average of $409.03 and a 200 day simple moving average of $482.60. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the prior year, the business posted $6.91 earnings per share. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be paid a $2.21 dividend. The ex-dividend date is Monday, June 16th. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 2.92%. UnitedHealth Group's payout ratio is 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.